Intraocular Methotrexate in the Treatment of Uveitis and Uveitic Cystoid Macular Edema

Ophthalmology

Volumn 116, Issue 4, 2009, Pages 797-801

  Taylor, Simon R J ^a   Habot Wilner, Zohar ^a   Pacheco, Patricio ^b   Lightman, Sue L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE; MITOMYCIN C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TRIAMCINOLONE ACETATE;

ADULT; AGED; ARTICLE; CATARACT; CILIARY DISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INJECTION SITE REACTION; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA PIGMENT EPITHELIOPATHY; SCORING SYSTEM; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; METHOTREXATE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITREOUS BODY;

EID: 63149196149     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.10.033     Document Type: Article

References (25)

1. Samson C.M., Waheed N., Baltatzis S., and Foster C.S. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 108 (2001) 1134-1139
2. Fishburne B.C., Wilson D.J., Rosenbaum J.T., and Neuwelt E.A. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115 (1997) 1152-1156
3. Smith J.R., Rosenbaum J.T., Wilson D.J., et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109 (2002) 1709-1716
4. Hardwig P.W., Pulido J.S., Erie J.C., et al. Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma. Am J Ophthalmol 142 (2006) 883-885
5. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol 140 (2005) 509-516
6. Ferrante P., Ramsey A., Bunce C., and Lightman S. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Experiment Ophthalmol 32 (2004) 563-568
7. Kok H., Lau C., Maycock N., et al. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 112 (2005) 1916-1921
8. Antcliff R.J., Spalton D.J., Stanford M.R., et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108 (2001) 765-772
9. Young S., Larkin G., Branley M., and Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 29 (2001) 2-6
10. Hsu J. Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol 18 (2007) 235-239
11. Kuppermann B.D., Blumenkranz M.S., Haller J.A., et al., Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 125 (2007) 309-317
12. Jonas J.B., Kreissig I., and Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87 (2003) 24-27
13. Djalilian A.R., and Nussenblatt R.B. Immunosuppression in uveitis. Ophthalmol Clin North Am 15 (2002) 395-404 viii
14. Van Gelder R.N., and Kaplan H.J. Immunosuppression in uveitis therapy. Springer Semin Immunopathol 21 (1999) 179-190
15. Velez G., Boldt H.C., Whitcup S.M., et al. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma. Ophthalmic Surg Lasers 33 (2002) 329-333
16. Velez G., Yuan P., Sung C., et al. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch Ophthalmol 119 (2001) 1518-1524
17. Deng S.X., Penland S., Gupta S., et al. Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model. Invest Ophthalmol Vis Sci 47 (2006) 1516-1521
18. Jonas J.B., Degenring R.F., Kreissig I., et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 112 (2005) 593-598
19. Montesinos M.C., Desai A., and Cronstein B.N. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. Arthritis Res Ther 8 (2006) R53. http://arthritis-research.com/content/8/2/R53 Accessed October 24, 2008
20. Baig J.A., Iqbal M.P., Rehman R., et al. Anti-inflammatory role of methotrexate in adjuvant arthritis: effect on substance P and calcitonin gene-related peptide in thymus and spleen. J Coll Physicians Surg Pak 17 (2007) 490-494
21. Fine B.S., and Brucker A.J. Macular edema and cystoid macular edema. Am J Ophthalmol 92 (1981) 466-481
22. Newsom W.A., Hood C.I., Horwitz J.A., et al. Cystoid macular edema: histopathologic and angiographic correlations. A clinicopathologic case report. Trans Am Acad Ophthalmol Otolaryngol 76 (1972) 1005-1009
23. Tso M.O. Pathology of cystoid macular edema. Ophthalmology 89 (1982) 902-915
24. Lardenoye C.W., van Kooij B., and Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology 113 (2006) 1446-1449
25. Rothova A. Inflammatory cystoid macular edema. Curr Opin Ophthalmol 18 (2007) 487-492